• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属依赖性程序性细胞死亡相关lncRNA对胃癌的预后特征及天然药物敏感性预测

Metal-dependent programmed cell death-related lncRNA prognostic signatures and natural drug sensitivity prediction for gastric cancer.

作者信息

Song Xuesong, Hou Lin, Zhao Yuanyuan, Guan Qingtian, Li Zhiwen

机构信息

Department of Anesthesiology, First Hospital of Jilin University, Changchun, China.

First Hospital of Jilin University, Changchun, China.

出版信息

Front Pharmacol. 2022 Oct 21;13:1039499. doi: 10.3389/fphar.2022.1039499. eCollection 2022.

DOI:10.3389/fphar.2022.1039499
PMID:36339625
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9634547/
Abstract

Gastric cancer is one of the most important malignancies with poor prognosis. Ferroptosis and cuproptosis are newly discovered metal-dependent types of programmed cell death, which may directly affect the outcome of gastric cancer. Long noncoding RNAs (lncRNAs) can affect the prognosis of cancer with stable structures, which could be potential prognostic prediction factors for gastric cancer. Differentially expressed metal-dependent programmed cell death (PCD)-related lncRNAs were identified with DESeq2 and 's correlation analysis. Through GO and KEGG analyses and GSEA , we identified the potential effects of metal-dependent PCD-related lncRNAs on prognosis. Using Cox regression analysis with the LASSO method, we constructed a 12-lncRNA prognostic signature model. Also, we evaluated the prognostic efficiency with Kaplan-Meier (K-M) survival curve, receiver operating characteristic (ROC) curve, and decision curve analysis (DCA) methods. The sensitivities for antitumor drugs were then predicted with the pRRophetic method. Also, we discuss Chinese patent medicines and plant extracts that could induce metal-dependent programmed cell death. We constructed a metal-dependent PCD-related lncRNA-gene co-expression network. Also, a metal-dependent PCD-related gastric cancer prognostic signature model including 12 lncRNAs was constructed. The K-M survival curve revealed a poor prognosis in the high-risk group. ROC curve analysis shows that the AUC of our model is 0.766, which is better than that of other published models. Moreover, the half-maximum inhibitory concentration (IC50) for dasatinib, lapatinib, sunitinib, cytarabine, saracatinib, and vinorelbine was much lower among the high-risk group. Our 12 metal-dependent PCD-related lncRNA prognostic signature model may improve the OS prediction for gastric cancer. The antitumor drug sensitivity analysis results may also be helpful for individualized chemotherapy regimen design.

摘要

胃癌是预后较差的最重要恶性肿瘤之一。铁死亡和铜死亡是新发现的金属依赖性程序性细胞死亡类型,可能直接影响胃癌的预后。长链非编码RNA(lncRNA)可以通过稳定的结构影响癌症的预后,可能成为胃癌潜在的预后预测因子。利用DESeq2和相关性分析鉴定了差异表达的金属依赖性程序性细胞死亡(PCD)相关lncRNA。通过基因本体(GO)和京都基因与基因组百科全书(KEGG)分析以及基因集富集分析(GSEA),我们确定了金属依赖性PCD相关lncRNA对预后的潜在影响。使用Cox回归分析和LASSO方法,我们构建了一个包含12个lncRNA的预后特征模型。此外,我们用Kaplan-Meier(K-M)生存曲线、受试者工作特征(ROC)曲线和决策曲线分析(DCA)方法评估了预后效率。然后用pRRophetic方法预测抗肿瘤药物的敏感性。此外,我们还讨论了可诱导金属依赖性程序性细胞死亡的中成药和植物提取物。我们构建了一个金属依赖性PCD相关lncRNA-基因共表达网络。此外,构建了一个包含12个lncRNA的金属依赖性PCD相关胃癌预后特征模型。K-M生存曲线显示高危组预后较差。ROC曲线分析表明,我们模型的曲线下面积(AUC)为0.766,优于其他已发表的模型。此外,高危组中达沙替尼、拉帕替尼、舒尼替尼、阿糖胞苷、萨拉卡替尼和长春瑞滨的半数抑制浓度(IC50)要低得多。我们的12个金属依赖性PCD相关lncRNA预后特征模型可能会改善胃癌的总生存期(OS)预测。抗肿瘤药物敏感性分析结果也可能有助于个体化化疗方案的设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/937c1ed0a7a1/fphar-13-1039499-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/ee526949c031/fphar-13-1039499-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/1f5e61329b97/fphar-13-1039499-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/3bf3905b1529/fphar-13-1039499-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/b8c17be66e96/fphar-13-1039499-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/81e91f8b2d85/fphar-13-1039499-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/924ffbf9a21f/fphar-13-1039499-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/d002597275b8/fphar-13-1039499-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/937c1ed0a7a1/fphar-13-1039499-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/ee526949c031/fphar-13-1039499-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/1f5e61329b97/fphar-13-1039499-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/3bf3905b1529/fphar-13-1039499-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/b8c17be66e96/fphar-13-1039499-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/81e91f8b2d85/fphar-13-1039499-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/924ffbf9a21f/fphar-13-1039499-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/d002597275b8/fphar-13-1039499-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0461/9634547/937c1ed0a7a1/fphar-13-1039499-g008.jpg

相似文献

1
Metal-dependent programmed cell death-related lncRNA prognostic signatures and natural drug sensitivity prediction for gastric cancer.金属依赖性程序性细胞死亡相关lncRNA对胃癌的预后特征及天然药物敏感性预测
Front Pharmacol. 2022 Oct 21;13:1039499. doi: 10.3389/fphar.2022.1039499. eCollection 2022.
2
Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics.基于生物信息学构建铁死亡相关lncRNA模型以改善胃癌患者的预后评估
Front Genet. 2021 Aug 23;12:739470. doi: 10.3389/fgene.2021.739470. eCollection 2021.
3
A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.一种新型铜诱导细胞死亡相关 lncRNA 预后标志物与胃癌免疫浸润和临床价值相关。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10543-10559. doi: 10.1007/s00432-023-04916-7. Epub 2023 Jun 8.
4
Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.构建并验证一种与铜死亡相关的长链非编码RNA特征作为结肠癌的新型稳健预后模型。
Front Oncol. 2022 Jul 28;12:961213. doi: 10.3389/fonc.2022.961213. eCollection 2022.
5
A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.一种新型的铜死亡相关长链非编码RNA特征:对急性髓系白血病的预后和治疗价值
Front Oncol. 2022 Oct 7;12:966920. doi: 10.3389/fonc.2022.966920. eCollection 2022.
6
Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis.基于缺氧相关长链非编码RNA特征构建列线图以改善胃癌预后预测
Front Genet. 2020 Oct 20;11:570325. doi: 10.3389/fgene.2020.570325. eCollection 2020.
7
Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.鉴定和验证与铁死亡相关的 lncRNA 特征作为结肠癌的一种新的预后模型。
Front Immunol. 2022 Jan 26;12:783362. doi: 10.3389/fimmu.2021.783362. eCollection 2021.
8
Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.基于微阵列重新注释的胃癌 6-长链非编码 RNA 预后签名的鉴定。
Cancer Med. 2020 Jan;9(1):335-349. doi: 10.1002/cam4.2621. Epub 2019 Nov 19.
9
Infection-Related Long Non-Coding RNA Signatures Predict the Prognostic Status for Gastric Cancer Patients.感染相关的长链非编码RNA特征预测胃癌患者的预后状况
Front Oncol. 2021 Jul 27;11:709796. doi: 10.3389/fonc.2021.709796. eCollection 2021.
10
Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.可有效预测肝细胞癌预后的铜死亡相关长链非编码RNA模型。
World J Gastrointest Oncol. 2022 Oct 15;14(10):1981-2003. doi: 10.4251/wjgo.v14.i10.1981.

引用本文的文献

1
Emerging roles of tsRNAs in programmed cell death and disease therapeutics: challenges, opportunities, and future directions.tsRNAs在程序性细胞死亡和疾病治疗中的新作用:挑战、机遇与未来方向
Noncoding RNA Res. 2025 Jul 11;15:65-73. doi: 10.1016/j.ncrna.2025.07.003. eCollection 2025 Dec.
2
Construction of a novel disulfidptosis and cuproptosis-related lncRNA signature for predicting the clinical outcome and immune response in stomach adenocarcinoma.构建一种用于预测胃腺癌临床结局和免疫反应的新型双硫死亡和铜死亡相关lncRNA特征
Discov Oncol. 2025 Feb 24;16(1):230. doi: 10.1007/s12672-025-01969-7.
3
Mendelian randomization analysis of plasma proteins reveals potential novel tumor markers for gastric cancer.

本文引用的文献

1
Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma.铜死亡相关风险评分预测肝细胞癌的预后并描绘肿瘤微环境。
Front Immunol. 2022 Jul 11;13:925618. doi: 10.3389/fimmu.2022.925618. eCollection 2022.
2
The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies.瞬时受体电位(TRP)家族通道在恶性肿瘤中的调控作用及相关治疗策略。
Acta Pharm Sin B. 2022 Apr;12(4):1761-1780. doi: 10.1016/j.apsb.2021.11.001. Epub 2021 Nov 5.
3
Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance.
血浆蛋白的孟德尔随机化分析揭示了潜在的新型胃癌肿瘤标志物。
Sci Rep. 2025 Jan 28;15(1):3537. doi: 10.1038/s41598-025-88118-w.
4
lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer.lncRNAs 作为铜死亡介导的癌症的预后标志物和治疗靶点。
Clin Exp Med. 2024 Sep 26;24(1):226. doi: 10.1007/s10238-024-01491-0.
5
A disulfidptosis-related classification and risk signature identifies immunotherapy biomarkers and predicts prognosis in gastric cancer: An observational study.一种与二硫键错配相关的分类和风险特征可识别胃癌的免疫治疗生物标志物,并预测预后:一项观察性研究。
Medicine (Baltimore). 2024 May 31;103(22):e38398. doi: 10.1097/MD.0000000000038398.
6
Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications.长链非编码 RNA 在胃癌耐药中的作用:复杂机制与潜在临床应用。
Biomolecules. 2024 May 22;14(6):608. doi: 10.3390/biom14060608.
7
Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay.利用多种细胞死亡模式预测肺腺癌免疫检查点治疗的临床结局:基于多组学分析和体外检测。
Oncol Res. 2023 Dec 28;32(2):393-407. doi: 10.32604/or.2023.031134. eCollection 2023.
8
Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer.胃癌中与二硫化物诱导细胞程序性坏死相关基因及预后的综合分析
World J Clin Oncol. 2023 Oct 24;14(10):373-399. doi: 10.5306/wjco.v14.i10.373.
9
Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.基于单细胞技术的胰腺癌免疫微环境相关铜死亡相关 lncRNAs 的开发和验证。
Front Immunol. 2023 Sep 25;14:1220760. doi: 10.3389/fimmu.2023.1220760. eCollection 2023.
10
Study on the role and pharmacology of cuproptosis in gastric cancer.铜死亡在胃癌中的作用及药理学研究
Front Oncol. 2023 Mar 17;13:1145446. doi: 10.3389/fonc.2023.1145446. eCollection 2023.
环状 RNA 在胃癌转移和耐药中的新兴作用。
J Exp Clin Cancer Res. 2022 Jul 11;41(1):218. doi: 10.1186/s13046-022-02432-z.
4
A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma.一个新的铜死亡相关 LncRNA 特征可预测肝细胞癌的预后。
Sci Rep. 2022 Jul 5;12(1):11325. doi: 10.1038/s41598-022-15251-1.
5
Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review.胃食管腺癌中针对 HER2 靶向治疗的耐药机制:系统评价。
Cancer Treat Rev. 2022 Jul;108:102418. doi: 10.1016/j.ctrv.2022.102418. Epub 2022 May 30.
6
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study.在 KEYNOTE-062 三期临床试验中,肿瘤突变负荷与帕博利珠单抗联合或不联合化疗作为一线治疗胃癌的疗效相关。
Clin Cancer Res. 2022 Aug 15;28(16):3489-3498. doi: 10.1158/1078-0432.CCR-22-0121.
7
Cuproptosis: Cellular and molecular mechanisms underlying copper-induced cell death.铜死亡:铜诱导细胞死亡的细胞和分子机制。
Mol Cell. 2022 May 19;82(10):1786-1787. doi: 10.1016/j.molcel.2022.05.001.
8
Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway.铜死亡:脂酰化三羧酸循环蛋白介导的新型细胞死亡途径。
Signal Transduct Target Ther. 2022 May 13;7(1):158. doi: 10.1038/s41392-022-01014-x.
9
Identification of Tumor Mutation Burden, Microsatellite Instability, and Somatic Copy Number Alteration Derived Nine Gene Signatures to Predict Clinical Outcomes in STAD.肿瘤突变负荷、微卫星不稳定性和体细胞拷贝数改变的鉴定衍生出九个基因特征以预测STAD的临床结果。
Front Mol Biosci. 2022 Apr 11;9:793403. doi: 10.3389/fmolb.2022.793403. eCollection 2022.
10
Cuproptosis: a new form of programmed cell death.铜死亡:一种新的程序性细胞死亡形式。
Cell Mol Immunol. 2022 Aug;19(8):867-868. doi: 10.1038/s41423-022-00866-1. Epub 2022 Apr 22.